<html>
  <head>

    <meta http-equiv="content-type" content="text/html; charset=UTF-8">
  </head>
  <body>
    <header class="css-d92687">
      <h1 class="css-19v093x">Notes from UCSF Expert panel - March 10</h1>
      <div class="css-1x1jxeu">
        <div class="css-7kp13n">By</div>
        <div class="css-7ol5x1"><span class="css-1q5ec3n">Dr. Jordan
            Shlain, M.D.</span></div>
        <div class="css-8rl9b7">linkedin.com</div>
        <div class="css-zskk6u">7 min</div>
      </div>
      <div class="css-1890bmp"><a
href="https://getpocket.com/redirect?url=https%3A%2F%2Fwww.linkedin.com%2Fpulse%2Fnotes-from-ucsf-expert-panel-march-10-dr-jordan-shlain-m-d-"
          target="_blank" class="css-1neb7j1">View Original</a></div>
    </header>
    <div class="css-429vn2">
      <div role="main" class="css-yt2q7e">
        <div id="RIL_container">
          <div id="RIL_body">
            <div id="RIL_less">
              <div lang="en">
                <header><time>Published on March 12, 2020</time>
                  <div>
                    <div
                      data-impression-id="author_mini-profile_mini-card">
                      <section></section>
                    </div>
                  </div>
                </header>
                <section
data-redirect-url="https://www.linkedin.com/uas/login?session_redirect=https%3A%2F%2Fwww%2Elinkedin%2Ecom%2Fpulse%2Fnotes-from-ucsf-expert-panel-march-10-dr-jordan-shlain-m-d-">
                  <p><strong>University of California, San Francisco
                      BioHub Panel on COVID-19</strong></p>
                  <ul>
                    <li><strong>Panelists</strong></li>
                    <li>Joe DeRisi: UCSF’s top infectious disease
                      researcher. Co-president of ChanZuckerberg BioHub
                      (a JV involving UCSF / Berkeley / Stanford).
                      Co-inventor of the chip used in SARS epidemic.</li>
                    <li>Emily Crawford: COVID task force director.
                      Focused on diagnostics</li>
                    <li>Cristina Tato: Rapid Response Director.
                      Immunologist. </li>
                    <li>Patrick Ayescue: Leading outbreak response and
                      surveillance. Epidemiologist. </li>
                    <li>Chaz Langelier: UCSF Infectious Disease doc</li>
                  </ul>
                  <p>What’s below are essentially direct quotes from the
                    panelists. I bracketed the few things that are not
                    quotes.</p>
                  <ul>
                    <li><strong>Top takeaways </strong></li>
                    <li><strong>At this point, we are past containment.
                        Containment is basically futile. Our containment
                        efforts won’t reduce the number who get infected
                        in the US. </strong></li>
                    <li><strong>Now we’re just trying to slow the
                        spread, to help healthcare providers deal with
                        the demand peak. In other words, the goal of
                        containment is to "flatten the curve", to lower
                        the peak of the surge of demand that will hit
                        healthcare providers. And to buy time, in hopes
                        a drug can be developed. </strong></li>
                    <li><strong>How many in the community already have
                        the virus? No one knows.</strong></li>
                    <li><strong>We are moving from containment to care.
                      </strong></li>
                    <li><strong>We in the US are currently where at
                        where Italy was a week ago. We see nothing to
                        say we will be substantially different.</strong></li>
                    <li><strong>40-70% of the US population will be
                        infected over the next 12-18 months. After that
                        level you can start to get herd immunity. Unlike
                        flu this is entirely novel to humans, so there
                        is no latent immunity in the global population.</strong></li>
                    <li><strong>[We used their numbers to work out a
                        guesstimate of deaths— indicating about 1.5
                        million Americans may die. The panelists did not
                        disagree with our estimate. This compares to
                        seasonal flu’s average of 50K Americans per
                        year. </strong>Assume 50% of US population,
                      that’s 160M people infected. With 1% mortality
                      rate that's 1.6M Americans die over the next 12-18
                      months.<strong>] </strong></li>
                    <li><strong>The fatality rate is in the range of 10X
                        flu.</strong></li>
                    <li><strong>This assumes no drug is found effective
                        and made available.</strong></li>
                    <li><strong>The death rate varies hugely by age.
                        Over age 80 the mortality rate could be 10-15%.
                        [</strong>See chart by age Signe found online,
                      attached at bottom.] <strong> </strong></li>
                    <li><strong>Don’t know whether COVID-19 is seasonal
                        but if is and subsides over the summer, it is
                        likely to roar back in fall as the 1918 flu did</strong></li>
                    <li><strong>I can only tell you two things
                        definitively. Definitively it’s going to get
                        worse before it gets better. And we'll be
                        dealing with this for the next year at least.
                        Our lives are going to look different for the
                        next year.</strong></li>
                    <li><strong>What should we do now? What are you
                        doing for your family?</strong></li>
                    <li><strong>Appears one can be infectious before
                        being symptomatic. We don’t know how infectious
                        before symptomatic, but know that highest level
                        of virus prevalence coincides with symptoms. We
                        currently think folks are infectious 2 days
                        before through 14 days after onset of symptoms
                        (T-2 to T+14 onset).</strong></li>
                    <li>How long does the virus last?</li>
                    <li>On surfaces, best guess is 4-20 hours depending
                      on surface type (maybe a few days) but still no
                      consensus on this</li>
                    <li>The virus is very susceptible to common
                      anti-bacterial cleaning agents: bleach, hydrogen
                      peroxide, alcohol-based.</li>
                    <li>Avoid concerts, movies, crowded places.</li>
                    <li>We have cancelled business travel. </li>
                    <li>Do the basic hygiene, eg hand washing and
                      avoiding touching face.</li>
                    <li><strong>Stockpile your critical prescription
                        medications</strong>. Many pharma supply chains
                      run through China. Pharma companies usually hold
                      2-3 months of raw materials, so may run out given
                      the disruption in China’s manufacturing. </li>
                    <li>Pneumonia shot might be helpful. Not
                      preventative of COVID-19, but reduces your chance
                      of being weakened, which makes COVID-19 more
                      dangerous.</li>
                    <li>Get a flu shot next fall. Not preventative of
                      COVID-19, but reduces your chance of being
                      weakened, which makes COVID-19 more dangerous.</li>
                    <li><strong>We would say “Anyone over 60 stay at
                        home unless it’s critical”. </strong>CDC toyed
                      with idea of saying anyone over 60 not travel on
                      commercial airlines.</li>
                    <li><strong>We at UCSF are moving our “at-risk”
                        parents back from nursing homes, etc. to their
                        own homes</strong>. Then are not letting them
                      out of the house. The other members of the family
                      are washing hands the moment they come in.</li>
                    <li>Three routes of infection</li>
                    <li>Hand to mouth / face</li>
                    <li>Aerosol transmission</li>
                    <li>Fecal oral route</li>
                    <li><strong>What if someone is sick?</strong></li>
                    <li><strong>If someone gets sick, have them stay
                        home and socially isolate. There is very little
                        you can do at a hospital that you couldn’t do at
                        home. Most cases are mild. But if they are old
                        or have lung or cardio-vascular problems, read
                        on.</strong></li>
                    <li>If someone gets quite sick who is old (70+) or
                      with lung or cardio-vascular problems, take them
                      to the ER.</li>
                    <li>There is no accepted treatment for COVID-19. The
                      hospital will give supportive care (eg IV fluids,
                      oxygen) to help you stay alive while your body
                      fights the disease. ie to prevent sepsis.</li>
                    <li>If someone gets sick who is high risk (eg is
                      both old and has lung/cardio-vascular problems),
                      you can try to get them enrolled for
                      “compassionate use" of Remdesivir, a drug that is
                      in clinical trial at San Francisco General and
                      UCSF, and in China. Need to find a doc there in
                      order to ask to enroll. Remdesivir is an
                      anti-viral from Gilead that showed effectiveness
                      against MERS in primates and is being tried
                      against COVID-19. If the trials succeed it might
                      be available for next winter as production scales
                      up far faster for drugs than for vaccines. [<a
                        rel="nofollow noopener"
href="https://news.bloomberglaw.com/pharma-and-life-sciences/hundreds-of-corona-patients-allowed-to-try-gileads-ebola-drug">More</a>
                      I found online.]</li>
                    <li>Why is the fatality rate much higher for older
                      adults?</li>
                    <li>Your immune system declines past age 50</li>
                    <li>Fatality rate tracks closely with
                      “co-morbidity”, ie the presence of other
                      conditions that compromise the patient’s hearth,
                      especially respiratory or cardio-vascular illness.
                      These conditions are higher in older adults. </li>
                    <li>Risk of pneumonia is higher in older adults. </li>
                    <li><strong>What about testing to know if someone
                        has COVID-19? </strong> </li>
                    <li>Bottom line, there is not enough testing
                      capacity to be broadly useful. Here’s why.</li>
                    <li>Currently, there is no way to determine what a
                      person has other than a PCR test. No other test
                      can yet distinguish "COVID-19 from flu or from the
                      other dozen respiratory bugs that are
                      circulating”.</li>
                    <li>A Polymerase Chain Reaction (PCR) test can
                      detect COVID-19’s RNA. However they still don’t
                      have confidence in the test’s specificity, ie they
                      don’t know the rate of false negatives. </li>
                    <li>The PCR test requires kits with reagents and
                      requires clinical labs to process the kits. </li>
                    <li>While the kits are becoming available, the lab
                      capacity is not growing. </li>
                    <li>The leading clinical lab firms, Quest and
                      Labcore have capacity to process 1000 kits per
                      day. For the nation.</li>
                    <li>Expanding processing capacity takes “time,
                      space, and equipment.” And certification. ie it
                      won’t happen soon.</li>
                    <li>UCSF and UCBerkeley have donated their research
                      labs to process kits. But each has capacity to
                      process only 20-40 kits per day. And are not
                      clinically certified.</li>
                    <li>Novel test methods are on the horizon, but not
                      here now and won’t be at any scale to be useful
                      for the present danger.</li>
                    <li><strong>How well is society preparing for the
                        impact?</strong></li>
                    <li>Local hospitals are adding capacity as we speak.
                      UCSF’s Parnassus campus has erected “triage tents”
                      in a parking lot. They have converted a ward to
                      “negative pressure” which is needed to contain the
                      virus. They are considering re-opening the
                      shuttered Mt Zion facility.</li>
                    <li>If COVID-19 affected children then we would be
                      seeing mass departures of families from cities.
                      But thankfully now we know that kids are not
                      affected.</li>
                    <li>School closures are one the biggest societal
                      impacts. We need to be thoughtful before we close
                      schools, especially elementary schools because of
                      the knock-on effects. If elementary kids are not
                      in school then some hospital staff can’t come to
                      work, which decreases hospital capacity at a time
                      of surging demand for hospital services. </li>
                    <li>Public Health systems are prepared to deal with
                      short-term outbreaks that last for weeks, like an
                      outbreak of meningitis. They do not have the
                      capacity to sustain for outbreaks that last for
                      months. Other solutions will have to be found.</li>
                    <li>What will we do to handle behavior changes that
                      can last for months?</li>
                    <li>Many employees will need to make accommodations
                      for elderly parents and those with underlying
                      conditions and immune-suppressed.</li>
                    <li>Kids home due to school closures</li>
                    <li>[Dr. DeRisi had to leave the meeting for a call
                      with the governor’s office. When he returned we
                      asked what the call covered.] The epidemiological
                      models the state is using to track and trigger
                      action. The state is planning at what point they
                      will take certain actions. ie what will trigger an
                      order to cease any gatherings of over 1000 people.
                    </li>
                    <li><strong>Where do you find reliable news?</strong></li>
                    <li>The John Hopkins Center for Health Security <a
                        rel="nofollow noopener"
                        href="http://www.centerforhealthsecurity.org/resources/COVID-19/">site</a>.
                      Which posts daily updates. The site says you can
                      sign up to receive a daily newsletter on COVID-19
                      by email. [I tried and the page times out due to
                      high demand. After three more tries I was
                      successful in registering for the newsletter.] </li>
                    <li>The New York Times is good on scientific
                      accuracy.</li>
                    <li><br>
                    </li>
                    <li><strong>Observations on China</strong></li>
                    <li>Unlike during SARS, China’s scientists are
                      publishing openly and accurately on COVID-19. </li>
                    <li>While China’s early reports on incidence were
                      clearly low, that seems to trace to their data
                      management systems being overwhelmed, not to any
                      bad intent.</li>
                    <li><strong>Wuhan has 4.3 beds per thousand while US
                        has 2.8 beds per thousand.</strong> Wuhan built
                      2 additional hospitals in 2 weeks. Even so, most
                      patients were sent to gymnasiums to sleep on cots.
                    </li>
                    <li>Early on no one had info on COVID-19. So China
                      reacted in a way unique modern history, except in
                      wartime. </li>
                    <li><strong>Every few years there seems another:
                        SARS, Ebola, MERS, H1N1, COVID-19. Growing
                        strains of antibiotic resistant bacteria. Are we
                        in the twilight of a century of medicine’s great
                        triumph over infectious disease?</strong></li>
                    <li>"We’ve been in a back and forth battle against
                      viruses for a million years." </li>
                    <li>But it would sure help if every country would
                      shut down their wet markets. </li>
                    <li>As with many things, the worst impact of
                      COVID-19 will likely be in the countries with the
                      least resources, eg Africa. See article on Wired
                      magazine on sequencing of virus from Cambodia.</li>
                  </ul>
                </section>
              </div>
            </div>
          </div>
        </div>
      </div>
    </div>
    <br>
  </body>
</html>